We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$28.2B
1-Year Est. Return
21.78%
This Fund
S&P 500
This Quarter
Est. Return
+17.1%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$14.1B
AUM Growth
+$1.4B
(+11%)
Cap. Flow
-$4.28B
Cap. Flow
% of AUM
-30.25%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
803
New
108
Increased
91
Reduced
295
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BSX.PRA
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
|
+$61M |
| 2 |
RTX Corp
RTX
|
+$38.2M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$15.5M |
| 4 |
Delta Air Lines
DAL
|
+$14.5M |
| 5 |
SWT
Stanley Black & Decker, Inc.
SWT
|
+$13.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$578M |
| 2 |
AGN
Allergan plc
AGN
|
+$67M |
| 3 |
BDXA
Becton, Dickinson and Company Depositary Shares, each Representing a 1/20th Interest in a Share of 6
BDXA
|
+$51.1M |
| 4 |
Alibaba
BABA
|
+$46.8M |
| 5 |
lululemon athletica
LULU
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.91% |
| 2 | Healthcare | 8.15% |
| 3 | Consumer Discretionary | 7.49% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
TE Connectivity
TEL
$62.1B
| $4.8M | 0.03% |
58,925
-3,771
| -6% | -$284K |
|
327
Thor Industries
THO
$4.13B
| $4.76M | 0.03% |
+44,710
| New | +$3.5M |
|
328
AES
AES
$10.6B
| $4.73M | 0.03% |
326,277
-20,880
| -6% | -$274K |
|
329
Simon Property Group
SPG
$76.8B
| $4.71M | 0.03% |
68,842
-4,405
| -6% | -$276K |
|
330
Trex
TREX
$4.57B
| $4.71M | 0.03% |
72,380
+9,700
| +15% | +$517K |
|
331
Phillips 66
PSX
$82.5B
| $4.69M | 0.03% |
65,241
-4,174
| -6% | -$296K |
|
|
EVBG
332
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $4.67M | 0.03% |
33,731
+9,530
| +39% | +$1.24M |
|
333
M&T Bank
MTB
$36.6B
| $4.66M | 0.03% |
44,786
-2,865
| -6% | -$302K |
|
334
Enterprise Products Partners
EPD
$83.6B
| $4.62M | 0.03% |
253,985
| – | – |
|
335
Castle Biosciences
CSTL
$725M
| $4.61M | 0.03% |
122,385
+34,681
| +40% | +$1.18M |
|
336
Weyerhaeuser
WY
$17.7B
| $4.58M | 0.03% |
203,939
-13,051
| -6% | -$264K |
|
337
NiSource
NI
$21.9B
| $4.57M | 0.03% |
200,948
-12,859
| -6% | -$310K |
|
338
Truist Financial
TFC
$64.7B
| $4.55M | 0.03% |
121,306
-7,749
| -6% | -$279K |
|
339
Sprout Social
SPT
$522M
| $4.41M | 0.03% |
163,448
-46,871
| -22% | -$1.03M |
|
|
VAPO
340
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $4.41M | 0.03% |
+13,448
| New | +$2.84M |
|
|
AXNX
341
DELISTED
Axonics, Inc. Common Stock
AXNX
| $4.35M | 0.03% |
123,931
+75,175
| +154% | +$2.59M |
|
342
Exelon
EXC
$48.4B
| $4.34M | 0.03% |
167,575
-9,784
| -6% | -$260K |
|
|
PING
343
DELISTED
Ping Identity Holding Corp.
PING
| $4.31M | 0.03% |
134,309
+93,523
| +229% | +$2.48M |
|
344
State Street
STT
$50.2B
| $4.3M | 0.03% |
67,749
-4,335
| -6% | -$262K |
|
345
Pentair
PNR
$10.8B
| $4.27M | 0.03% |
112,492
-7,200
| -6% | -$253K |
|
346
Teladoc Health
TDOC
$1.69B
| $4.26M | 0.03% |
22,326
+5,627
| +34% | +$986K |
|
347
Edison International
EIX
$30.7B
| $4.24M | 0.03% |
78,020
-4,982
| -6% | -$287K |
|
348
Chegg
CHGG
$121M
| $4.23M | 0.03% |
62,862
-1,419
| -2% | -$75.8K |
|
349
EverQuote
EVER
$960M
| $4.23M | 0.03% |
72,717
+923
| +1% | +$43.4K |
|
350
HDFC Bank
HDB
$121B
| $4.22M | 0.03% |
185,610
-3,658
| -2% | -$75.1K |
|
Similar funds
PCH
N
TWC
FDCDDQ
NA
Calamos Advisors's Q2 2020 Portfolio in Review
As of Q2 2020, Calamos Advisors held 803 positions worth $14.1B, up 11% from $12.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Calamos Advisors withdrew a net $4.28B in Q2 2020, closing 98 positions and reducing 295 holdings. Its most notable exit was Allergan plc, an estimated $67M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Calamos Advisors opened a new position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A worth $59.7M.
- Calamos Advisors's largest Q2 2020 buy was Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A: 569,916 shares worth $59.7M.
- Calamos Advisors added most to RTX Corp in Q2 2020, an estimated $38.2M increase.
- Calamos Advisors's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $578M.
- Calamos Advisors fully exited Allergan plc in Q2 2020, selling an estimated $67M.
- Calamos Advisors's ten largest holdings make up 20% of its $14.1B portfolio in Q2 2020.
- Calamos Advisors opened 108 new positions and closed 98 in Q2 2020.
- Calamos Advisors's portfolio value rose 11% quarter-over-quarter to $14.1B.
Based on Calamos Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.